Businesses looking to claim research and development tax credits must first establish which scheme they are eligible for. If you have identified that your activity qualifies for the relief – that is, that it seeks to overcome an uncertainty through the use of scientific or technological processes – then the next step is to identify whether your claim falls under the SME of RDEC scheme.
The SME scheme applies to businesses with under 500 employees and a turnover of less than €100m annually. If your company has more employees or a higher turnover, it falls into the R&D Expenditure Credit (RDEC) scheme. This offers a 12% credit for both profit and loss-making organisations that have engaged in R&D activity. Let’s take a look at the RDEC scheme in more detail.
How much can I claim?
As of 1 January 2018, the RDEC rate is 12%, so for every £1 spend on R&D activity, up to 10p (after Corporation Tax reduction) can be claimed back. The after-tax cash benefit, then, is 10%. For profitable companies, this is calculated as a reduction in the Corporation Tax payable, while loss-making organisations with no tax payable can claim the R&D tax credits as a cash benefit.
As an example, let’s assume Company A is profitable, and has spent £500,000 on research and development for this tax year.
£500,000 spend x 12% enhancement rate = £60,000 above the line credit
£60,000 – 19% CT rate (in this case £11,400) = £48,600
The after-tax benefit in this example, then is £48,600.
What are the qualifying costs?
R&D tax credits can only be claimed on so-called qualifying costs. These are expenses directly associated with the project and can include:
- Employee costs, including wages NI contributions and pension payments
- Consumables and utilities
- Certain software costs
- Payment of clinical trial volunteers
This list is not exhaustive so speak to your tax advisor for full details on which costs you can claim for.
In terms of timescales, you can claim for any of the above expenditure from the moment your business began work on resolving the particular scientific or technological uncertainty you are seeking a solution to. At this point, you should already have identified the problem and confirmed that there is no current, viable solution.
You must stop claiming for the tax relief once a working prototype the solves the issue is developed, or until you cease to work on the project.
Making a claim
A claim for R&D tax relief is made as a part of Corporation Tax return submission. Once you have gathered and totalled the qualifying expenditure, this is used as in the example above to calculate the credit you’re owed. It’s also advisable to submit documents to evidence the nature of your work and how the challenges were overcome alongside the calculations.
To ensure your claim is accurate, enlist the help of a tax specialist when making your calculations and submitting your Corporation Tax return. This ensures no accidental errors are made and that you receive the full amount of relief owed to you.
This article does not necessarily reflect the opinions of the editors or management of EconoTimes.


Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Same sparkle, different story: how lab-grown diamonds are transforming the market
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 



